C07AA05 propranolol
CARDIOVASCULAR SYSTEM ›BETA BLOCKING AGENTS ›BETA BLOCKING AGENTS ›Beta blocking agents, non-selective
健保收載品項 TFDA 在效許可證 41 FDA 已核准
台灣藥品與外觀
健保收載品名:"人人" 健心寧錠、"仙台" 普洛諾錠40公絲(普潘奈)、"信東"普朗膜衣錠40毫克(普潘奈)、"信隆"健心寧錠、"優生"整脈錠、"優良"心律整錠10毫克(普潘奈)、"優良"心律整錠20毫克(普潘奈)、"優良"心律整錠40毫克(普潘奈)、"利達"維心平錠10毫克(普潘奈)、"利達"維心平錠40毫克(普潘奈)、"台裕"迪適倍錠40毫克(鹽酸普潘奈)、"培力"律順錠、"壽元"利其心錠40公絲(鹽酸普潘奈)、"強生"英得來錠20公絲、"應元"能整脈注射液、"應元"降壓錠(健心寧)
資料來源:食藥署「西藥許可證」+「藥品 ATC 碼」+「藥品外觀」+「藥品仿單或外盒」開放資料。外觀照與仿單連結指向食藥署原始檔。
適應症
台灣 TFDA 核准適應症
- 狹心症、不整律(上心室性不整律、心室性心搏過速)、原發性及腎性高血壓、偏頭痛、控制原發性震顫、控制焦慮性心搏過速、甲狀腺毒症的補助劑、親鉻細胞瘤、(必須於注意事項註明:用於親鉻細胞瘤之治療時、不可單獨使用、而必須與α-BLOCKERS合用)。
- 狹心症、不整律(上心室性不整律、心室性心博過速)、原發性及腎性高血壓、偏頭痛、控制原發性震顛、控制焦慮性心博過速、甲狀腺毒症的輔助劑、親鉻細胞瘤。
- 狹心症、不整律(上心室性不整律、心室性心搏過速)、原發性及腎性高血壓、偏頭痛、控制原發性震顛、控制焦慮性心搏過速、甲狀腺毒症的補助劑、親鉻細胞瘤。
- 狹心症、不整律(上心室性不整律、心室性心搏過速)、原發性及腎性高血壓、偏頭痛、控制原發性震顛、控制焦慮性心搏過速、甲狀腺毒症的輔助劑、親鉻細胞瘤。
- 狹心症、不整律(上心室性不整律、心室性心搏過速)、原發性及腎性高血壓、偏頭痛、控制原發性震顫、控制焦慮性心搏過速、甲狀腺毒症的輔助劑、親鉻細胞瘤。
- 狹心症、不整律(上心室性不整律、心室性心摶過速)、原發性及腎性高血壓、偏頭痛、控制原發性震顛、控制焦慮性心摶過速、甲狀腺毒症的輔助劑、親鉻細胞瘤。
- 狹心症、不整律(上心室性不整律、心室性性心搏過速、原發性及腎性高血壓、偏頭痛、控制原發性震顛、控制焦慮性心搏過速、甲狀腺毒症的輔助劑、親鉻細胞瘤。
- 狹心症、不整率(上心室性不整律、心室性心搏過速)、原發性及腎性高血壓、偏頭痛、控制原發性震顫、控制焦慮性心搏過速、甲狀腺毒症的輔助劑、親鉻細胞瘤。
- 狹心症、不整律(上心室不整律、心室性心博過速)、原發性及腎性高血壓、偏頭痛、控制原發性震顫、控制焦慮性心博過速、甲狀腺毒症的輔助劑、親鉻細胞瘤。
- 狹心症、不整律(上心室性不整律、心室性心博過速)原發性及腎性高血壓、偏頭痛、控制原發性震顛、控制焦慮性心博過速、甲狀腺毒症的輔助劑、親鉻細胞瘤。
- 狹心症、不整律(上心室性不整律、心室性心博過速)原發性及腎性高血壓、偏頭痛、控制原發性震顛、控制焦慮性心博過速、甲狀腺毒症的輔助劑、親銘細胞瘤。
- 狹心症、不整律(上心室性不整律、心室性心搏過速)原發性及腎性高血壓、偏頭痛、控制原發性震顛、控制焦慮性心博過速、甲狀腺毒症的輔助劑、親鉻細胞瘤。
美國 FDA 適應症(英文原文對照)
INDICATIONS AND USAGE Hypertension Propranolol hydrochloride tablets, USP are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol hydrochloride tablets, USP are not indicated in the management of hypertensive emergencies. Angina Pectoris Due to Coronary Atherosclerosis Propranolol hydrochloride tablets, USP are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Atrial Fibrillation Propranolol hydrochloride tablets, USP are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. Myocardial Infarction Propranolol hydrochloride tablets, USP are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. Migraine Propranolol hydrochloride tablets, USP are indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. Essential Tremor Propranolol hydrochloride tablets, USP are indicated in the management of familial or hereditary essential tremor. Familial or essential tremor consists of involuntary, rhythmic, oscillatory movements, usually limited to the upper limbs. It is absent at rest, but occurs when the limb is held in a fixed posture or position against gravity and during active movement. Propranolol hydrochloride tablets, USP cause a reduction in the tremor amplitude, but not in the tremor frequency. Propranolol hydrochloride tablets, USP are not indicated for the treatment of tremor associated with Parkinsonism. Hypertrophic Subaortic Stenosis Propranolol hydrochloride tablets, USP improve NYHA functional class in symptomatic patients with hypertrophic subaortic stenosis. Pheochromocytoma Propranolol hydrochloride tablets, USP are indicated as an adjunct to alpha-adrenergic blockade to control blood pressure and reduce symptoms of catecholamine-secreting tumors.
Hypertension Propranolol hydrochloride tablets, USP are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol hydrochloride tablets, USP are not indicated in the management of hypertensive emergencies.
Angina Pectoris Due to Coronary Atherosclerosis Propranolol hydrochloride tablets, USP are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris.
Atrial Fibrillation Propranolol hydrochloride tablets, USP are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response.
Myocardial Infarction Propranolol hydrochloride tablets, USP are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable.
Migraine Propranolol hydrochloride tablets, USP are indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use.
Essential Tremor Propranolol hydrochloride tablets, USP are indicated in the management of familial or hereditary essential tremor. Familial or essential tremor consists of involuntary, rhythmic, oscillatory movements, usually limited to the upper limbs. It is absent at rest, but occurs when the limb is held in a fixed posture or position against gravity and during active movement. Propranolol hydrochloride tablets, USP cause a reduction in the tremor amplitude, but not in the tremor frequency. Propranolol hydrochloride tablets, USP are not indicated for the treatment of tremor associated with Parkinsonism.
Hypertrophic Subaortic Stenosis Propranolol hydrochloride tablets, USP improve NYHA functional class in symptomatic patients with hypertrophic subaortic stenosis.
Pheochromocytoma Propranolol hydrochloride tablets, USP are indicated as an adjunct to alpha-adrenergic blockade to control blood pressure and reduce symptoms of catecholamine-secreting tumors.
資料來源:食藥署西藥許可證適應症(中文)、openFDA US SPL(英文,僅供對照)。
健保給付規定
查無健保特殊給付規定條款;本藥品依一般健保藥品支付規定給付。
實證補充
本藥品尚無實證補充整理(未來新增 Review/指引知識時補列)。
台灣藥品與適應症:食藥署西藥許可證+ATC+外觀+仿單開放資料 · FDA:openFDA US SPL · 健保給付:健保署「全民健康保險藥品給付規定」(更新日 2026-06-09)· 實證補充:人工彙整。 本頁為資訊整理,實際給付與適應症以主管機關公告為準。